Search
for
Sort by
Research 61–90 of 191
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Diagnostic approach to low‐renin hypertension
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Clinical applications of antiandrogens
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Polycystic ovarian syndrome
- Androgen antagonists in androgen target tissues
- Physical methods for topical skin drug delivery: concepts and applications
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Contraceptive use in acne
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- An antimicrobial microneedle patch promotes functional healing of infected wounds through controlled release of adipose tissue-derived apoptotic vesicles
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- A Case of Familial Male-limited Precocious Puberty with a Novel Mutation
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Hyperadrenocorticism in Ferrets
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol